Clinical Trials
2 trialsNCT00003509 2020-12-19
Antineoplaston Therapy in Treating Patients With Stage IV Melanoma
Burzynski Research Institute
Phase 2 Terminated
NCT00003514 2013-07-10
Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy
National Cancer Institute (NCI)
Phase 2 Withdrawn